Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/07/2007 | EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
11/07/2007 | EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
11/07/2007 | EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators |
11/07/2007 | EP1401408A4 Controlled heat induced rapid delivery of pharmaceuticals from skin depot |
11/07/2007 | EP1361225B1 Compounds substituted with bicyclic amino groups |
11/07/2007 | EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects |
11/07/2007 | EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base |
11/07/2007 | EP1165523B1 Neurotrophic substituted pyrimidines |
11/07/2007 | EP1144671B1 Enriched central nervous system cell populations |
11/07/2007 | EP1042288B1 Tripeptidyl peptidase inhibitors |
11/07/2007 | EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
11/07/2007 | CN101068827A Polymorphs of sarsasapogenin |
11/07/2007 | CN101068801A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
11/07/2007 | CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
11/07/2007 | CN101068788A Quinoline as allosteric enhancers of the gaba-b receptors |
11/07/2007 | CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
11/07/2007 | CN101068595A Cgrp受体拮抗剂 Cgrp receptor antagonists |
11/07/2007 | CN101068534A Pharmaceutical compositions comprising levetiracetam and process for their preparation |
11/07/2007 | CN101066997A Human antibodies that bind human IL-12 and methods for producing |
11/07/2007 | CN101066439A Wind dispelling and obstruction eliminating capsule and its prepn |
11/07/2007 | CN101066412A Brain nourishing and eyesight improving tea |
11/07/2007 | CN101066396A Externally applied for treating hemicrania |
11/07/2007 | CN101066355A Chinese medicine prepn for treating toothache and its prepn process |
11/07/2007 | CN101066352A Chinese medicine prepn for treating headache during menstruation |
11/07/2007 | CN101066349A Chinese herbal medicine composition for treating dizziness |
11/07/2007 | CN101066332A Chinese medicine composition for treating headache during menstruation |
11/07/2007 | CN101066325A Chinese herbal medicine liniment for treating paralysis |
11/07/2007 | CN101066291A Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn |
11/07/2007 | CN101066289A Medicine for treating Qi deficiency |
11/07/2007 | CN101066288A Medicine composition containing notoginseng leaf extract and its use |
11/07/2007 | CN101066278A Medicine use of energy mixture |
11/07/2007 | CN101066276A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
11/07/2007 | CN101066268A Application of compound 6-furfuryl amino purine in preparing medicine for treating brain tissue oxidizing damage |
11/07/2007 | CN101066267A Solid oral medicine composition containing aripiprazole microcrystal |
11/07/2007 | CN101066266A Organic salt of pyritinol and its prepn process |
11/07/2007 | CN101066244A Small volume vincamine injection and its prepn process |
11/07/2007 | CN101066083A Health tea of aizoon stonecrop herb |
11/07/2007 | CN100347306C Method and means for producing protein with prospective post-translation modification |
11/07/2007 | CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
11/07/2007 | CN100347171C Pyridine compounds and their prepn and application as Dopamine D4 receptor agonist |
11/07/2007 | CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity |
11/07/2007 | CN100347169C 喹唑啉衍生物 Quinazoline derivatives |
11/07/2007 | CN100347164C Benzofuryl derivatives and their use |
11/07/2007 | CN100347158C Bicyclic compound |
11/07/2007 | CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
11/07/2007 | CN100346824C 自体t-细胞疫苗材料和方法 Autologous t- vaccine MATERIALS AND METHODS Cell |
11/07/2007 | CN100346823C Enamel matrix protein compositions for modulating immune response |
11/07/2007 | CN100346808C Medicine for treating senile dementia and application of related Chinese medicinal composition |
11/07/2007 | CN100346792C Benzothiazole derivatives as adenosine receptor ligands |
11/07/2007 | CN100346790C Application of (+) North America coptisine |
11/07/2007 | CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
11/07/2007 | CN100346779C Liquid pharmaceutical composition |
11/07/2007 | CN100346776C Remedies |
11/06/2007 | US7291738 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis |
11/06/2007 | US7291734 N-(4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridin-2-yl)sulfonamides, e.g., 2-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]-4-trifluoromethyl-benzamide; steroid sulfatase inhibitors used to treat diseases including acne |
11/06/2007 | US7291732 Isomeric fused pyrrolocarbazoles and isoindolones |
11/06/2007 | US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
11/06/2007 | US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease |
11/06/2007 | US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
11/06/2007 | US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders |
11/06/2007 | US7291636 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders |
11/06/2007 | US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy |
11/06/2007 | US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases |
11/06/2007 | US7291629 Neurotrophin antagonist compositions |
11/06/2007 | US7291627 E.g., 8-chloro-3,11-dimethyl-5,6-dihydroimidazo[5,1-a]- beta -carboline methane sulfonate; used for reducing alertness and/or for accelerating the onset of sleep |
11/06/2007 | US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders |
11/06/2007 | US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction |
11/06/2007 | US7291613 Inhibitors of p38 kinase |
11/06/2007 | US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
11/06/2007 | US7291599 Such as amistatin and leuhistin; for control of inflammation; topical creams, gels, ointments |
11/06/2007 | US7291454 Comprises antisense olignucleotides, ribozymes, DNA and guide sequences; animal models; genetic engineering; for use in drug screening |
11/06/2007 | US7291451 Modulation of pericyte proliferation |
11/06/2007 | US7291347 Solubility, permeability, and bioavailability; oral dosage |
11/06/2007 | US7291344 Administering a botulinum toxin |
11/06/2007 | US7291330 MD-1 inhibitors as immune suppressants |
11/06/2007 | CA2427576C Benzodiazepine derivatives as gaba a receptor modulators |
11/06/2007 | CA2388564C Caspase inhibitor |
11/06/2007 | CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
11/06/2007 | CA2266556C Nmda (n-methyl-d-aspartate) antagonists |
11/06/2007 | CA2263927C Heterocyclic thioesters and ketones |
11/06/2007 | CA2241666C Tricyclic compounds, their production and use |
11/06/2007 | CA2114251C Igf-1 to improve the neural condition |
11/03/2007 | CA2587129A1 Methods and compositions for stem cell therapies |
11/02/2007 | CA2587002A1 Stem cells derived from bone marrow for tissue regeneration |
11/01/2007 | WO2007124394A1 Substituted biphenyl carboxylic acids and derivatives thereof |
11/01/2007 | WO2007124351A1 Terphenyl derivatives for treatment of alzheimer' s disease |
11/01/2007 | WO2007124318A1 Inhibitors of c-fms kinase |
11/01/2007 | WO2007124136A1 Use of 4-amino-piperidines for treating sleep disorders |
11/01/2007 | WO2007123953A2 Phosphodiesterase 4 inhibitors |
11/01/2007 | WO2007123269A1 Azolecarboxamide derivative |
11/01/2007 | WO2007123234A1 Antiepileptic action enhancer |
11/01/2007 | WO2007123187A1 Pharmaceutical composition for conformational disease |
11/01/2007 | WO2007123186A1 Pharmaceutical product |
11/01/2007 | WO2007123153A1 Capsule for oral administration |
11/01/2007 | WO2007122976A1 Therapeutic agent or development inhibitor of polyglutamine disease |
11/01/2007 | WO2007122975A1 Hgf precursor protein mutant and activated form thereof |
11/01/2007 | WO2007122815A1 Bivalent antibody directed against bir1 |
11/01/2007 | WO2007122634A2 Pyrimidinediones as tyrosine kinase inhibitors |
11/01/2007 | WO2007122274A1 Acetylcholinesterase-inhibiting compounds for treating alzheimer's disease |
11/01/2007 | WO2007122241A1 Compounds which potentiate ampa receptor and uses thereof in medicine |